Showing results (511-520 of 1,155) with videos related to

Sort By:
Pageof 116
Journal of Minimally Invasive Gynecology|September 14, 2025
Optimizing New Urogynecology Consultations: Advanced Practice Providers are KeyKristina A Burger, Joseph B Rigdon, Terra L Schmitt, et al.
International Journal of Colorectal Disease|September 9, 2017
The influence of hospital volume on long-term oncological outcome after rectal cancer surgeryFrederik H W Jonker, Jan A W Hagemans, Jacobus W A Burger, et al.
The Oncologist|August 25, 2018
Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing ParadigmRebecca C Arend, Michael D Toboni, Allison M Montgomery, et al.
Blood|June 4, 2009
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406Maite P Quiroga, Kumudha Balakrishnan, Antonina V Kurtova, et al.
Annales De Chirurgie|January 24, 2002
[Thyroid cancers: the Geneva experience]F Triponez, S Simon, J Robert, et al.
Blood|December 30, 2016
Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLKEkaterina Kim, Christian Hurtz, Stefan Koehrer, et al.
Digestive Surgery|March 3, 2021
The Accuracy of the Surgical Peritoneal Cancer Index in Patients with Peritoneal Metastases of Colorectal CancerNadine L de Boer, Alexandra R M Brandt-Kerkhof, Eva V E Madsen, et al.
Leukemia & Lymphoma|October 3, 2018
Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinibJacqueline C Barrientos, Jan A Burger, John C Byrd, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2018
Comparing diagnostic accuracy of <sup>18</sup>F-FDG-PET/CT, contrast enhanced CT and combined imaging in patients with suspected vascular graft infectionsLars Husmann, Martin W Huellner, Bruno Ledergerber, et al.
Gynecologic Oncology|November 25, 1998
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancersB J Monk, D S Alberts, R A Burger, et al.
Pageof 116